Consensus Statements in 2018

Filter By:

Article Type
Year
  • This Consensus Statement presents the barriers that currently prevent the timely development and implementation of novel and rapid antimicrobial susceptibility testing platforms, including the costs involved, uptake of new tools, legal and regulatory aspects, difficulties conducting clinical trials and quality control, and presents possible solutions.

    • Alex van Belkum
    • Till T. Bachmann
    • Wm. Michael Dunne Jr
    Consensus StatementOpen Access